Metabolic and stone disorders
Glomerular Hyperfiltration: An Early Marker of Nephropathy in Fabry Disease.
Author(s): Riccio E, Sabbatini M, Bruzzese D, Annicchiarico Petruzzelli L, Pellegrino A, Spinelli L, Esposito R, Imbriaco M, Feriozzi S, Pisani A
Source: Nephron 2018 Nov 22;:1-8
Publication date: 2018-11-22
Long-term renal outcomes of APRT deficiency presenting in childhood.
Author(s): Runolfsdottir HL, Palsson R, Agustsdottir IM, Indridason OS, Edvardsson VO
Source: Pediatr Nephrol 2018 Nov 15;
Publication date: 2018-11-15
The aminoglycoside geneticin permits translational readthrough of the CTNS W138X nonsense mutation in fibroblasts from patients with nephropathic cystinosis.
Author(s): Brasell EJ, Chu L, El Kares R, Seo JH, Loesch R, Iglesias DM, Goodyer P
Source: Pediatr Nephrol 2018 Nov 9;
Publication date: 2018-11-9
α-galactosidase A deficiency promotes von Willebrand factor secretion in models of Fabry disease.
Author(s): Kang JJ, Kaissarian NM, Desch KC, Kelly RJ, Shu L, Bodary PF, Shayman JA
Source: Kidney Int 2018 Nov 20;
Publication date: 2018-11-20
Role of Calcium to Citrate Ratio in Predicting Stone Formation in Idiopathic Hypercalciuria Children (2-12 Years Old).
Author(s): Kompani F, Valavi E, Amuri P, Mohtasham N
Source: J Ren Nutr 2018 Oct 12;
Publication date: 2018-10-12
Thematic areasHereditary glomerulopathies Immune glomerulopathies Tubulopathies Metabolic and stone disorders Thrombotic microangiopathies AD structural kidney disorders Renal malformations and ciliopathies Obstructive nephropathies Pediatric CKD and dialysis Pediatric kidney transplantation
Recently added publications